BIOMAT Database Logo BIOMAT Database Logo

Development of 5-lipoxygenase inhibitor. 1987

M Toda, and H Nakai, and S Sakuyama, and Y Arai, and S Kaneko, and H Ohno, and T Okegawa
Ono Pharmaceutical Co., Ltd., Osaka, Japan.

UI MeSH Term Description Entries
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001091 Arachidonate Lipoxygenases Enzymes catalyzing the oxidation of arachidonic acid to hydroperoxyarachidonates. These products are then rapidly converted by a peroxidase to hydroxyeicosatetraenoic acids. The positional specificity of the enzyme reaction varies from tissue to tissue. The final lipoxygenase pathway leads to the leukotrienes. EC 1.13.11.- . Arachidonic Acid Lipoxygenase,Lipoxygenase, Arachidonic Acid,Lipoxygenases, Arachidonate
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D016859 Lipoxygenase Inhibitors Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. 5-Lipoxygenase Inhibitor,Lipoxygenase Inhibitor,12-Lipoxygenase Inhibitors,15-Lipoxygenase Inhibitors,5-Lipoxygenase Inhibitors,Arachidonate 12-Lipoxygenase Inhibitors,Arachidonate 15-Lipoxygenase Inhibitors,Arachidonate 5-Lipoxygenase Inhibitors,Inhibitors, Lipoxygenase,12 Lipoxygenase Inhibitors,12-Lipoxygenase Inhibitors, Arachidonate,15 Lipoxygenase Inhibitors,15-Lipoxygenase Inhibitors, Arachidonate,5 Lipoxygenase Inhibitor,5 Lipoxygenase Inhibitors,5-Lipoxygenase Inhibitors, Arachidonate,Arachidonate 12 Lipoxygenase Inhibitors,Arachidonate 15 Lipoxygenase Inhibitors,Arachidonate 5 Lipoxygenase Inhibitors,Inhibitor, 5-Lipoxygenase,Inhibitor, Lipoxygenase,Inhibitors, 12-Lipoxygenase,Inhibitors, 15-Lipoxygenase,Inhibitors, 5-Lipoxygenase,Inhibitors, Arachidonate 12-Lipoxygenase,Inhibitors, Arachidonate 15-Lipoxygenase,Inhibitors, Arachidonate 5-Lipoxygenase
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

M Toda, and H Nakai, and S Sakuyama, and Y Arai, and S Kaneko, and H Ohno, and T Okegawa
The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.
April 1992, International journal of immunopharmacology,
M Toda, and H Nakai, and S Sakuyama, and Y Arai, and S Kaneko, and H Ohno, and T Okegawa
RBx 7,796: A novel inhibitor of 5-lipoxygenase.
December 2006, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
M Toda, and H Nakai, and S Sakuyama, and Y Arai, and S Kaneko, and H Ohno, and T Okegawa
Protection of dopaminergic neurons by 5-lipoxygenase inhibitor.
October 2013, Neuropharmacology,
M Toda, and H Nakai, and S Sakuyama, and Y Arai, and S Kaneko, and H Ohno, and T Okegawa
A-78773: a selective, potent 5-lipoxygenase inhibitor.
January 1993, Journal of lipid mediators,
M Toda, and H Nakai, and S Sakuyama, and Y Arai, and S Kaneko, and H Ohno, and T Okegawa
Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.
October 1992, The Journal of rheumatology,
M Toda, and H Nakai, and S Sakuyama, and Y Arai, and S Kaneko, and H Ohno, and T Okegawa
Effect of 5-lipoxygenase inhibitor on canine pancreatic allotransplantation.
February 1991, Transplantation proceedings,
M Toda, and H Nakai, and S Sakuyama, and Y Arai, and S Kaneko, and H Ohno, and T Okegawa
Stereoselective metabolism of the 5-lipoxygenase inhibitor A-78773.
November 1994, Annals of the New York Academy of Sciences,
M Toda, and H Nakai, and S Sakuyama, and Y Arai, and S Kaneko, and H Ohno, and T Okegawa
A practical synthesis of 5-lipoxygenase inhibitor MK-0633.
June 2010, The Journal of organic chemistry,
M Toda, and H Nakai, and S Sakuyama, and Y Arai, and S Kaneko, and H Ohno, and T Okegawa
Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor.
December 1983, Prostaglandins,
M Toda, and H Nakai, and S Sakuyama, and Y Arai, and S Kaneko, and H Ohno, and T Okegawa
Antiallergic activity of AA-861, a 5-lipoxygenase inhibitor.
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
Copied contents to your clipboard!